SH PHARMA (02607.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec24

Shanghai Pharmaceutical Smart Supply Chain Technology Co., Ltd. Established with a Registered Capital of 20 Million Yuan

06:34

Dec15

Shanghai Pharmaceutical's Subsidiary's Sotalol Hydrochloride Tablets Pass Consistency Evaluation

08:14

Dec14

Description of 2025 China Enterprise Science and Technology Innovation Power Ranking in Wholesale and Retail Industry

11:07

Dec5

Shanghai Pharmaceutical Terminates Cooperation Agreement with Shengnuo Biotechnology for Novel Acid Inhibitor X842

09:36

Nov28

Shanghai Pharmaceutical Subsidiary's Tramadol Hydrochloride Injection Passes Consistency Evaluation

08:26

Nov11

HSBC Research Maintains Ratings for Shanghai Pharmaceuticals and Sinopharm with Target Price Adjustments

02:53

Schedules & Filings

Schedules

Filings

Feb6

Distribution Plan(CST)

Cash dividend 0.1321 HKD

Dec31

Distribution Plan(CST)

Cash dividend 0.1321 HKD

Dec29

Distribution Plan(CST)

Cash dividend 0.1321 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More